Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arndt Hartmann

Showing results (461-470 of 933) with videos related to

Pageof 94
Sort By:
Oncotarget|October 6, 2017
Predictive value of molecular subtyping in NMIBC by RT-qPCR of ERBB2, ESR1, PGR and MKI67 from formalin fixed TUR biopsiesJohannes Breyer, Ralph Markus Wirtz, Wolfgang Otto, et al.
Anticancer Research|December 1, 2017
Comparison of <i>PD-L1</i> mRNA Expression Measured with the CheckPoint Typer® Assay with PD-L1 Protein Expression Assessed with Immunohistochemistry in Non-small Cell Lung CancerRamona Erber, Robert Stöhr, Stefanie Herlein, et al.
Clinical Genitourinary Cancer|March 12, 2018
High CDKN2A/p16 and Low FGFR3 Expression Predict Progressive Potential of Stage pT1 Urothelial Bladder CarcinomaJohannes Breyer, Ralph M Wirtz, Philipp Erben, et al.
Molecular and Cellular Biology|April 7, 2010
The Ras effector RASSF2 controls the PAR-4 tumor suppressorHoward Donninger, Luke Hesson, Michele Vos, et al.
Virchows Archiv : an International Journal of Pathology|March 8, 2013
Increased detection rates of EGFR and KRAS mutations in NSCLC specimens with low tumour cell content by 454 deep sequencingEvgeny A Moskalev, Robert Stöhr, Ralf Rieker, et al.
Biochimica Et Biophysica Acta|February 11, 2014
Piwi-like 1 and 4 gene transcript levels are associated with clinicopathological parameters in renal cell carcinomasOmar Al-Janabi, Sven Wach, Elke Nolte, et al.
PPAR Research|July 30, 2009
Cyclooxygenase 2 (COX2) and Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Are Stage-Dependent Prognostic Markers of Malignant MelanomaStefanie Meyer, Thomas Vogt, Michael Landthaler, et al.
Annals of Diagnostic Pathology|May 21, 2015
Sclerosing epithelioid fibrosarcoma of the kidney: clinicopathologic and molecular study of a rare neoplasm at a novel locationCarsten-Henning Ohlmann, Ines B Brecht, Kerstin Junker, et al.
The Journal of Molecular Diagnostics : JMD|March 23, 2010
Development of a diagnostic microarray assay to assess the risk of recurrence of prostate cancer based on PITX2 DNA methylationPhilipp Schatz, Dimo Dietrich, Thomas Koenig, et al.
Cancers|February 21, 2020
Accelerated Partial Breast Irradiation: Macrophage Polarisation Shift Classification Identifies High-Risk Tumours in Early Hormone Receptor-Positive Breast CancerSören Schnellhardt, Ramona Erber, Maike Büttner-Herold, et al.
Pageof 94

Showing results (461-470 of 933) with videos related to

Sort By:
Pageof 94
Oncotarget|October 6, 2017
Predictive value of molecular subtyping in NMIBC by RT-qPCR of ERBB2, ESR1, PGR and MKI67 from formalin fixed TUR biopsiesJohannes Breyer, Ralph Markus Wirtz, Wolfgang Otto, et al.
Anticancer Research|December 1, 2017
Comparison of <i>PD-L1</i> mRNA Expression Measured with the CheckPoint Typer® Assay with PD-L1 Protein Expression Assessed with Immunohistochemistry in Non-small Cell Lung CancerRamona Erber, Robert Stöhr, Stefanie Herlein, et al.
Clinical Genitourinary Cancer|March 12, 2018
High CDKN2A/p16 and Low FGFR3 Expression Predict Progressive Potential of Stage pT1 Urothelial Bladder CarcinomaJohannes Breyer, Ralph M Wirtz, Philipp Erben, et al.
Molecular and Cellular Biology|April 7, 2010
The Ras effector RASSF2 controls the PAR-4 tumor suppressorHoward Donninger, Luke Hesson, Michele Vos, et al.
Virchows Archiv : an International Journal of Pathology|March 8, 2013
Increased detection rates of EGFR and KRAS mutations in NSCLC specimens with low tumour cell content by 454 deep sequencingEvgeny A Moskalev, Robert Stöhr, Ralf Rieker, et al.
Biochimica Et Biophysica Acta|February 11, 2014
Piwi-like 1 and 4 gene transcript levels are associated with clinicopathological parameters in renal cell carcinomasOmar Al-Janabi, Sven Wach, Elke Nolte, et al.
PPAR Research|July 30, 2009
Cyclooxygenase 2 (COX2) and Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Are Stage-Dependent Prognostic Markers of Malignant MelanomaStefanie Meyer, Thomas Vogt, Michael Landthaler, et al.
Annals of Diagnostic Pathology|May 21, 2015
Sclerosing epithelioid fibrosarcoma of the kidney: clinicopathologic and molecular study of a rare neoplasm at a novel locationCarsten-Henning Ohlmann, Ines B Brecht, Kerstin Junker, et al.
The Journal of Molecular Diagnostics : JMD|March 23, 2010
Development of a diagnostic microarray assay to assess the risk of recurrence of prostate cancer based on PITX2 DNA methylationPhilipp Schatz, Dimo Dietrich, Thomas Koenig, et al.
Cancers|February 21, 2020
Accelerated Partial Breast Irradiation: Macrophage Polarisation Shift Classification Identifies High-Risk Tumours in Early Hormone Receptor-Positive Breast CancerSören Schnellhardt, Ramona Erber, Maike Büttner-Herold, et al.
Pageof 94